Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents

Giovanna Garufi, Luisa Carbognin, Francesco Schettini, Elia Seguí, Alba Di Leone, Antonio De Franco, Ida Paris, Giovanni Scambia, Giampaolo Tortora, Alessandra Fabi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)4064-4084
Number of pages20
JournalCancers
Volume14
DOIs
Publication statusPublished - 2022

Keywords

  • PARP-inhibitors
  • immune checkpoint inhibitors
  • neoadjuvant chemotherapy
  • platinum agents
  • predictive biomarkers
  • target therapies
  • triple-negative breast cancer

Cite this